IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
These instructions will get you a copy of the project up and running on your local machine for development and testing purposes.
This project uses Quarkus, the Supersonic Subatomic Java Framework. If you want to learn more about Quarkus, please visit its website: https://quarkus.io/. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results